Cardiac Amyloidosis.

Ann Intern Med

Division of Rheumatology, Renaissance School of Medicine, State University of New York at Stony Brook, Stony Brook, New York (P.D.G.).

Published: March 2023

AI Article Synopsis

  • Amyloidosis is a serious condition caused by the buildup of misfolded proteins in body tissues, particularly affecting the heart.
  • Cardiac amyloidosis can lead to diastolic heart failure and has often been underestimated in its impact and prognosis.
  • Recent improvements in detection and treatment underscore the need for early diagnosis and management of cardiac amyloidosis, which this article discusses.

Article Abstract

Amyloidosis is a pathologic and clinical condition resulting from the accumulation of insoluble aggregates of misfolded proteins in tissues. Extracellular deposition of amyloid fibrils in the myocardium leads to cardiac amyloidosis, which is often overlooked as a cause of diastolic heart failure. Although cardiac amyloidosis was previously believed to have a poor prognosis, recent advances in diagnosis and treatment have emphasized the importance of early recognition and changed management of this condition. This article provides an overview of cardiac amyloidosis and summarizes current screening, diagnosis, evaluation, and treatment options.

Download full-text PDF

Source
http://dx.doi.org/10.7326/AITC202303210DOI Listing

Publication Analysis

Top Keywords

cardiac amyloidosis
16
cardiac
4
amyloidosis
4
amyloidosis amyloidosis
4
amyloidosis pathologic
4
pathologic clinical
4
clinical condition
4
condition accumulation
4
accumulation insoluble
4
insoluble aggregates
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!